EpiVax Therapeutics, Inc. Company Profile, Contacts & Intelligence

Biotechnology188 Valley St2 employeesFounded 2017
1 contact with email or phone data1 with email data1 with phone data
Employees
2
Company source estimate
Reachable Contacts
1
Visible contacts with email or phone data
Contacts With Email
1
1 of 1 visible contacts

EpiVax Therapeutics, Inc. Overview

EpiVax Therapeutics ("EVT"), founded in 2017, employs a world-leading technology, developed over 22 years by EpiVax, to design vaccines that aim to activate the body’s T cells to cure or prevent disease in the host. EVT’s pipeline includes a COVID-19 vaccine and a personalized bladder cancer vaccine.

Headquarters
188 Valley St
Industry
Biotechnology
Founded
2017

EpiVax Therapeutics, Inc. Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

1 contact with contact data
1 with email data and 1 with phone data in the visible sample.

EpiVax Therapeutics, Inc. People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Compare Similar Companies to EpiVax Therapeutics, Inc.

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
Cartesian Therapeutics Biotechnology Research 85 View company
Nabsys Biotechnology Research 71 View company
EpiVax, Inc. Biotechnology Research 48 View company
Volastra Therapeutics Biotechnology 44 View company
Palvella Therapeutics Biotechnology Research 28 View company
VeroScience, LLC Biotechnology Research 8 View company
Matrivax Biotechnology Research 5 View company
ABLi Therapeutics Biotechnology Research 2 View company
Beech Tree Labs, Inc. Biotechnology Not listed View company
Magenta Therapeutics Biotechnology Research Not listed View company